279 related articles for article (PubMed ID: 6805957)
1. Toward eradication of poliomyelitis by combined use of killed and live vaccines.
Melnick JL
Cardiovasc Res Cent Bull; 1982; 20(3):49-60. PubMed ID: 6805957
[No Abstract] [Full Text] [Related]
2. [Advantages and inconveniences of inactive and live antipoliomyelitis vaccines].
Melnick JL
Bull World Health Organ; 1978; 56(5):677-98. PubMed ID: 310715
[No Abstract] [Full Text] [Related]
3. [Problems of prevention and control of poliomyelitis in Poland].
Mazurowska-Magdzik W; Bucholc B; Janaszek-Seydlitz W; Szkoda T; Magdzik W
Przegl Epidemiol; 2010; 64(3):341-7. PubMed ID: 20976944
[TBL] [Abstract][Full Text] [Related]
4. The natural history of poliomyelitis in Israel, 1949-1982.
Goldblum N; Swartz T; Gerichter CB; Handsher R; Lasch EE; Melnick JL
Prog Med Virol; 1984; 29():115-23. PubMed ID: 6366916
[No Abstract] [Full Text] [Related]
5. Poliomyelitis vaccines in Belgium: 20 years of experience.
Andre FE
Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
[No Abstract] [Full Text] [Related]
6. Combined use of live and killed vaccines to control poliomyelitis in tropical areas.
Melnick JL
Dev Biol Stand; 1981; 47():265-73. PubMed ID: 7227655
[No Abstract] [Full Text] [Related]
7. Poliomyelitis vaccination benefits--versus risk.
Assaad F
Dev Biol Stand; 1979; 43():141-50. PubMed ID: 520666
[TBL] [Abstract][Full Text] [Related]
8. [Findings on the success of vaccination and revaccination with live and inactivated vaccines against poliomyelitis].
Dostal V; Haenzel I; Sturm W
Schweiz Med Wochenschr; 1969 Sep; 99(37):1322-4. PubMed ID: 4309326
[No Abstract] [Full Text] [Related]
9. The poliomyelitis story: a scientific hegira.
Horstmann DM
Yale J Biol Med; 1985; 58(2):79-90. PubMed ID: 2994307
[TBL] [Abstract][Full Text] [Related]
10. Changing poliovirus vaccine policy can be controversial at best.
Faden H
Adv Pediatr Infect Dis; 1997; 13():305-32. PubMed ID: 9544317
[No Abstract] [Full Text] [Related]
11. Polio eradication in India: how far are we from reaching the goal?
Banerjee K; Sahu S; Bandyopadhyay S
Indian J Pediatr; 2001 Mar; 68 Suppl 1():S6-14. PubMed ID: 11411387
[No Abstract] [Full Text] [Related]
12. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
13. Poliovirus vaccines: live or dead.
Ogra PL; Faden HS
J Pediatr; 1986 Jun; 108(6):1031-3. PubMed ID: 3712146
[No Abstract] [Full Text] [Related]
14. Medicine and the media: polio still paralyses (Albert Sabin, Jonas Salk).
Dixon B
Br J Hosp Med; 1977 Dec; 18(6):595. PubMed ID: 342023
[No Abstract] [Full Text] [Related]
15. [Poliomyelitis vaccination in Denmark].
Petersen I
Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
[No Abstract] [Full Text] [Related]
16. Criteria for control of infectious diseases with poliomyelitis as an example.
Evans AS
Prog Med Virol; 1984; 29():141-65. PubMed ID: 6322231
[No Abstract] [Full Text] [Related]
17. [Poliomyelitis in the Netherlands].
Dekking F
Ned Tijdschr Geneeskd; 1978 Aug; 122(31):1142-3. PubMed ID: 673050
[No Abstract] [Full Text] [Related]
18. Combined use of inactivated and oral poliovirus vaccines in a large-scale campaign in refugee camps and host communities – Kenya, December 2013.
Wkly Epidemiol Rec; 2014 Mar; 89(12):127-32. PubMed ID: 24707518
[No Abstract] [Full Text] [Related]
19. Herd effect and virus eradication with use of killed poliovirus vaccine.
Salk D
Dev Biol Stand; 1981; 47():247-55. PubMed ID: 6262150
[TBL] [Abstract][Full Text] [Related]
20. Advantages and disadvantages of killed and live poliomyelitis vaccines.
Melnick JL
Bull World Health Organ; 1978; 56(1):21-38. PubMed ID: 307445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
